Aspira Women’s Health Inc. (NASDAQ:AWH – Get Free Report)’s share price was up 7% during trading on Monday . The company traded as high as $0.23 and last traded at $0.20. Approximately 1,207,977 shares traded hands during mid-day trading, an increase of 745% from the average daily volume of 142,991 shares. The stock had previously closed at $0.19.
Wall Street Analysts Forecast Growth
Separately, StockNews.com started coverage on Aspira Women’s Health in a research report on Sunday, January 12th. They issued a “hold” rating for the company.
View Our Latest Stock Report on AWH
Aspira Women’s Health Stock Up 7.0 %
Institutional Inflows and Outflows
A hedge fund recently raised its stake in Aspira Women’s Health stock. B. Riley Wealth Advisors Inc. raised its position in shares of Aspira Women’s Health Inc. (NASDAQ:AWH – Free Report) by 33.8% during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 316,294 shares of the company’s stock after acquiring an additional 79,898 shares during the quarter. B. Riley Wealth Advisors Inc. owned approximately 1.90% of Aspira Women’s Health worth $256,000 at the end of the most recent quarter. Institutional investors and hedge funds own 12.19% of the company’s stock.
About Aspira Women’s Health
Aspira Women’s Health, Inc engages in the provision of bio-analytic and diagnostic services. Its product, OVA1, is a serum test for identifying women of having malignant ovarian tumor. Its bio-analytical solutions helps physicians diagnose, treat, and improve gynecologic health outcomes for women. The company was founded on December 9, 1993 and is headquartered in Austin, TX.
Read More
- Five stocks we like better than Aspira Women’s Health
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- How to Protect Your Portfolio When Inflation Is Rising
- Learn Technical Analysis Skills to Master the Stock Market
- 3 Tech Stocks Defying Sector Weakness and Thriving in 2025
- What Does Downgrade Mean in Investing?
- Despite Challenges Novo Nordisk Plans to Crush GLP-1 Competitors
Receive News & Ratings for Aspira Women's Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspira Women's Health and related companies with MarketBeat.com's FREE daily email newsletter.